Skip to main content

Verapamil Hydrochloride Extended-Release Tablets

Type of Posting: Revision Bulletin

Posting Date: 31–Jan–2013

Official Date: 01–Feb–2013

Expert Committee: Monographs—Small Molecules 2

Reason for Revision: Compliance

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 2 Expert Committee has revised the Verapamil Hydrochloride Extended-Release Tablets monograph. The purpose for this revision is to add Dissolution Test 6 for a recently approved generic drug product.

The Verapamil Hydrochloride Extended-Release Tablets Revision Bulletin supersedes the currently official monograph. This Revision Bulletin will be incorporated in the Second Supplement to USP 36–NF 31.

Should you have any questions, please contact Sujatha Ramakrishna Ph.D., M.B.A. (301-816-8349 or sxr@usp.org).